PRESS RELEASE
News
-
-
PRESS RELEASE
Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company
Tharimmune, Inc. and Intract Pharma to merge, creating transformative oral biologics company. Merger expected to enhance pipeline growth, innovation, and patient outcomes in the biologics market -
-
PRESS RELEASE
Significant Metallurgical Advancement: Moving Toward a New Industry Standard for LiFePO4 Battery Feedstock
St-Georges Metallurgy Corp., a leader in mineral processing technologies, advances lithium processing with a novel one-step LiFePO4 production process. Collaboration with partners aims for cost-effective battery feedstock production and environmental sustainability -
-
-
PRESS RELEASE
NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID
NanoViricides, Inc. reports filing of Annual Report on Form 10-K for fiscal year 2024, financial updates, and plans for Phase II clinical trials of antiviral drug NV-387 -
REGULATED PRESS RELEASE
Statement of transactions in own shares from September 23, 2024 to September 27, 2024
-
REGULATED PRESS RELEASE
Déclaration des transactions sur actions propres réalisées du 23/09/2024 au 27/09/2024
-
PRESS RELEASE
Medacta Hosts Inaugural Capital Markets Day, Showcasing Responsible Innovation and Effective Growth Strategy
Medacta Group SA hosts its first Capital Markets Day, presenting responsible innovation and effective growth strategy to investors. Key areas include patient-focused commitment, product development, and global market expansion
